APA (7th ed.) Citation

Kang, F., Wang, Y., Cai, F., Wu, L., Han, L., Yin, Q., & Bian, Y. (2026). Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. PLoS ONE, 21(2), 1. https://doi.org/10.1371/journal.pone.0342548

Chicago Style (17th ed.) Citation

Kang, Fengjiao, Yin Wang, Fengqun Cai, Liuyun Wu, Lizhu Han, Qinan Yin, and Yuan Bian. "Disproportionality Analysis of Fondaparinux Associated Adverse Events Based on the FDA Adverse Event Reporting System." PLoS ONE 21, no. 2 (2026): 1. https://doi.org/10.1371/journal.pone.0342548.

MLA (9th ed.) Citation

Kang, Fengjiao, et al. "Disproportionality Analysis of Fondaparinux Associated Adverse Events Based on the FDA Adverse Event Reporting System." PLoS ONE, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.pone.0342548.